HI
BIO icon

HBK Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

HBK Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,981
Closed -$932K – 636
2019
Q2 		$932K Sell
2,981
-12,019
-80% -$3.6M 0.01% 439
2019
Q1 		$4.58M Buy
15,000
+5,900
+65% +$1.59M 0.05% 343
2018
Q4 		$2.11M Buy
9,100
+3,600
+65% +$966K 0.02% 466
2018
Q3 		$1.72M Sell
5,500
-1,320
-19% -$410K 0.01% 569
2018
Q2 		$1.97M Buy
6,820
+3,820
+127% +$1.05M 0.01% 493
2018
Q1 		$750K Buy
3,000
+100
+3% +$25.5K 0.01% 680
2017
Q4 		$692K Sell
2,900
-696
-19% -$169K 0.01% 682
2017
Q3 		$799K Buy
+3,596
New +$809K 0.01% 688
2016
Q4 		– Sell
-2,851
Closed -$467K – 730
2016
Q3 		$467K Buy
2,851
+1,173
+70% +$178K ﹤0.01% 651
2016
Q2 		$240K Sell
1,678
-1,566
-48% -$223K ﹤0.01% 889
2016
Q1 		$444K Buy
+3,244
New +$426K ﹤0.01% 755
2015
Q4 		– Sell
-1,662
Closed -$223K – 976
2015
Q3 		$223K Buy
+1,662
New +$239K ﹤0.01% 918
2013
Q4 		– Sell
-3,975
Closed -$467K – 895
2013
Q3 		$467K Buy
3,975
+1,201
+43% +$142K 0.01% 646
2013
Q2 		$311K Buy
+2,774
New +$325K ﹤0.01% 675

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

HBK Investments's BIO Position: Q3 2019 in Review

HBK Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2019, closing a stake of 2,981 shares — an estimated $932K sold.

HBK Investments first reported a position in BIO in Q2 2013 and held it in 14 quarters. The position peaked at $4.58M in Q1 2019. 355 funds tracked by Wall St. Rank hold BIO as of Q3 2019.

  • HBK Investments reported no remaining Bio-Rad Laboratories Class A position as of Q3 2019 after selling out during the quarter.
  • HBK Investments sold 2,981 Bio-Rad Laboratories Class A shares in Q3 2019, an estimated $932K.
  • HBK Investments first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 14 quarters.
  • HBK Investments's Bio-Rad Laboratories Class A position peaked at $4.58M in Q1 2019.
  • 355 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2019.

Based on HBK Investments's 13F filing for Q3 2019, filed 14 Nov 2019.